Mark J. Hancock

25.2k total citations · 4 hit papers
238 papers, 8.6k citations indexed

About

Mark J. Hancock is a scholar working on Pharmacology, Pathology and Forensic Medicine and Economics and Econometrics. According to data from OpenAlex, Mark J. Hancock has authored 238 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 182 papers in Pharmacology, 92 papers in Pathology and Forensic Medicine and 52 papers in Economics and Econometrics. Recurrent topics in Mark J. Hancock's work include Musculoskeletal pain and rehabilitation (182 papers), Spine and Intervertebral Disc Pathology (92 papers) and Health Systems, Economic Evaluations, Quality of Life (52 papers). Mark J. Hancock is often cited by papers focused on Musculoskeletal pain and rehabilitation (182 papers), Spine and Intervertebral Disc Pathology (92 papers) and Health Systems, Economic Evaluations, Quality of Life (52 papers). Mark J. Hancock collaborates with scholars based in Australia, United States and Denmark. Mark J. Hancock's co-authors include Christopher G. Maher, Rob Herbert, James H. McAuley, Jane Latimer, Lucíola da Cunha Menezes Costa, Daniel Steffens, Bart W. Koes, Andrew J. McLachlan, Steven J. Kamper and Leonardo Oliveira Pena Costa and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Mark J. Hancock

219 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Perceived Effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status

2010 451 citations Christopher G. Maher, Mark J. Hancock et al. profile →
The prognosis of acute and persistent low-back pain: a meta-analysis

2012 451 citations Christopher G. Maher, Mark J. Hancock et al. profile →
Prevention of Low Back Pain

2016 327 citations Daniel Steffens, Christopher G. Maher et al. profile →
Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial

2023 100 citations Peter Kent, Terry Haines et al. profile →

Peers

Countries citing papers authored by Mark J. Hancock

Since Specialization

Citations

This map shows the geographic impact of Mark J. Hancock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Hancock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Hancock more than expected).

Fields of papers citing papers by Mark J. Hancock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Hancock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Hancock. The network helps show where Mark J. Hancock may publish in the future.

Co-authorship network of co-authors of Mark J. Hancock

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Hancock. A scholar is included among the top collaborators of Mark J. Hancock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Hancock. Mark J. Hancock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How Robust is the Evidence for Prehabilitation in Cancer Surgery?: A Systematic Review and Fragility Index Analysis 2025 ·Annals of Surgical Oncology ·Sarah Cook, Xiaoqiu Liu, Mark J. Hancock, Michael J. Solomon, Cherry Koh, (unknown), Sascha Karunaratne, Kate Alexander, Daniel Steffens	0
2	Wearable sensor technologies for individuals with back pain: a scoping review 2025 ·Pain Management ·(unknown), (unknown), Mark J. Hancock, (unknown), (unknown), (unknown), Ulrike H. Mitchell, (unknown), (unknown), Anton E. Bowden	0
3	The smallest worthwhile effect of surgery versus non-surgical treatments for sciatica: a benefit-harm trade-off study 2025 ·Journal of physiotherapy ·(unknown), Manuela L. Ferreira, Harrison J Hansford, Christopher G. Maher, Joshua R Zadro, Chung‐Wei Christine Lin, Ashish D. Diwan, James H. McAuley, Mark J. Hancock, Ian A. Harris, Giovanni E Ferreira	1
4	Clinician experiences in providing reassurance for patients with low back pain in primary care: a qualitative study 2024 ·Journal of physiotherapy ·(unknown), Simon French, Adrian C. Traeger, Julie Ayre, Mark J. Hancock, Hazel Jenkins	0
5	Implementation of back to living well, a community-based program for the tertiary prevention of low back pain: a study protocol 2024 ·BMC Musculoskeletal Disorders ·Luciana Macedo, (unknown), (unknown), Julie Richardson, Joy C. MacDermid, Mark J. Hancock, Michele C. Battié, Bruno Tirotti Saragiotto, Jill A. Hayden, Alison Rushton, Tara Packham, (unknown), Steven R. Bray, Meridith Griffin, (unknown), (unknown), (unknown)	0
6	Patients with worse disability respond best to cognitive functional therapy for chronic low back pain: a pre-planned secondary analysis of a randomised trial 2024 ·Journal of physiotherapy ·Mark J. Hancock, Anne Smith, Peter O’Sullivan, Robert Schütze, J.P. Cañeiro, Jan Hartvigsen, Kieran O’Sullivan, Alison H. McGregor, Terry Haines, Alistair Vickery, Amity Campbell, Peter Kent	2
7	A Decision Aid for Patients Considering Surgery for Sciatica: Codesign and User‐Testing With Patients and Clinicians 2024 ·Health Expectations ·Julie Ayre, (unknown), Hazel Jenkins, Kirsten McCaffery, Christopher G. Maher, Mark J. Hancock	1
8	Low back pain of disc, sacroiliac joint, or facet joint origin: a diagnostic accuracy systematic review 2023 ·EClinicalMedicine ·(unknown), Mark J. Hancock, Sweekriti Sharma, Saurab Sharma, Ian A. Harris, Steven P. Cohen, John Magnussen, Christopher G. Maher, Adrian C. Traeger	20
9	A review of patient recruitment in randomised controlled trials of preoperative exercise 2023 ·Clinical Trials ·Daniel Steffens, Michael J. Solomon, Jane Young, Paula R. Beckenkamp, (unknown), Cherry Koh, Mark J. Hancock	3
10	Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer 2023 ·Cancers ·Daniel Steffens, Natasha C Pocovi, (unknown), Kim Delbaere, Mark J. Hancock, Cherry Koh, Linda Denehy, Kimberley S. van Schooten, Michael J. Solomon	8
11	Test procedures and positive diagnostic criteria of the upper limb tension tests differ: a systematic review of the DiTA database 2023 ·Brazilian Journal of Physical Therapy ·Arianne P. Verhagen, (unknown), Mark J. Hancock, David Anderson	4
12	General practitioner experiences using a low back pain management booklet aiming to decrease non-indicated imaging for low back pain 2022 ·SHILAP Revista de lepidopterología ·Hazel Jenkins, Niamh Moloney, Simon French, Christopher G. Maher, Blake F. Dear, John Magnussen, Mark J. Hancock	4
13	Feasibility of testing the effectiveness of a theory-informed intervention to reduce imaging for low back pain: a pilot cluster randomised controlled trial 2022 ·Pilot and Feasibility Studies ·Hazel Jenkins, Simon French, (unknown), Niamh Moloney, Christopher G. Maher, John Magnussen, Blake F. Dear, Mark J. Hancock	2
14	The available evidence on the effectiveness of 10 common approaches to the management of non‐specific low back pain: An evidence map 2022 ·European Journal of Pain ·Hazel Jenkins, Giovanni E Ferreira, Aron Downie, Christopher G. Maher, Rachelle Buchbinder, Mark J. Hancock	7
15	Unique considerations for exercise programs to prevent future low back pain: the patient perspective 2021 ·Pain ·Julie Ayre, Hazel Jenkins, Kirsten McCaffery, Christopher G. Maher, Mark J. Hancock	7
16	What are the effects of diagnostic imaging on clinical outcomes in patients with low back pain presenting for chiropractic care: a matched observational study 2021 ·Chiropractic & Manual Therapies ·Hazel Jenkins, Alice Kongsted, Simon French, Tue Secher Jensen, (unknown), Jan Hartvigsen, Mark J. Hancock	7
17	Healthcare expenditure and its predictors in a cohort of Australians living with sciatica 2020 ·European Spine Journal ·(unknown), Chung‐Wei Christine Lin, Mark J. Hancock, Ian A. Harris, Jane Latimer, Christopher G. Maher, Andrew J. McLachlan, Stephanie Mathieson, Bart W. Koes, Richard O. Day, Laurent Billot, Stephen Jan, Blake Angell	0
18	A randomized clinical trial comparing the McKenzie method and motor control exercises in people with chronic low back pain and a directional preference: 1-year follow-up 2018 ·Physiotherapy ·(unknown), Evangelos Pappas, Mark J. Hancock, Helen Clare, Rafael Zambelli Pinto, (unknown), Paulo H. Ferreira	18
19	Effects of kinesiotaping on foot posture in participants with pronated foot: A quasi-randomised, double-blind study 2013 ·Physiotherapy ·Alejandro Luque-Suárez, Gabriel Gijón-Noguerón, Francisco Javier Barón-López, María Teresa Labajos Manzanares, Julia M. Hush, Mark J. Hancock	35
20	A Chiropractic scholar visits from Denmark: a report on the chiropractic research seminar 2013 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·Michael Swain, Alice Kongsted, Aron Downie, Mark J. Hancock	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact